Improved Therapeutic Efficacy of MT102, a New Anti-Inflammatory Agent, via a Self-Microemulsifying Drug Delivery System, in Ulcerative Colitis Mice
Kshitis Chandra Baral, Sang Hoon Lee, Jae Geun Song, Seong Hoon Jeong, Hyo-Kyung Han, Guy Van den Mooter · 2023
Read Improved Therapeutic Efficacy of MT102, a New Anti-Inflammatory Agent, via a Self-Microemulsifying Drug Delivery System, in Ulcerative Colitis Mice by Kshitis Chandra Baral, Sang Hoon Lee, Jae Geun Song, Seong Hoon Jeong, Hyo-Kyung Han, Guy Van den Mooter (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10747691.txt.
Description
A plant-derived anti-inflammatory barely dissolves in water, so swallowing it plain does little good. Kshitis Chandra Baral and co-authors fix that with a self-mixing oil carrier in a 2023 study. The drug, MT102, comes from two medicinal plants.
The best mix formed droplets near 177 nanometers wide. Its marker compound poured out fifteen times faster than the raw drug. In mice with colon inflammation, the carrier form eased disease clearly. The plain drug showed no such effect. Weight loss stayed under five percent on the carrier form. Two flare signals in tissue dropped as well.
Catalog record
| CREATOR | Kshitis Chandra Baral, Sang Hoon Lee, Jae Geun Song, Seong Hoon Jeong, Hyo-Kyung Han, Guy Van den Mooter |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |